Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 138 record(s)

Req # A-2020-000961

The most current Risk Management Plan (RMP) and RMP review report for Novolin (Insulin) associated with any of the following Drug Identification Numbers (DIN): 02024217, 02025248, 02024314, 02024322, 02024225, 02024233, 02024268, 02024284 by Novo Nordisk Canada Inc.

Organization: Health Canada

0 page(s)
October 2020

Req # A-2020-00026

Obtain a copy of any document, including any kind of cost estimate, that Elections Canada possesses that will let me see how much the next election will cost, should the next federal election be called, for example, in 2020 or 2021, in the event that the opposing parties bring down Justin Trudeau’s Liberal government. Also including all extra costs due to the covid-19/coronavirus pandemic for the next federal election (including any briefing notes prepared for the Chief Electoral Officer on a potential federal election in the short-term with this Liberal minority government in 2020 or 2021).

Organization: Elections Canada

0 page(s)
September 2020

Req # A-2020-000794

Requesting the rates of male babies and female babies born as a result of fertility treatments, by fertility treatment, for each fertility clinic in Ontario over the last 10 years.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000600

All internal correspondence pertaining to the product DRYFT nicotine pouches, Kretek International INC and Kretek International Canada.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000609

All records prepared at the Assistant Deputy Minister (ADM) level and above from May 1, 2020 to July 24, 2020, including those prepared for the minister and minister's office, related to the return of the National Hockey League (NHL), and related to an agreement between the federal government and the NHL.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000734

All records related to the July 24, 2020 meeting between Air Canada and the following public office holders: Marc Garneau, Marc Roy, Patty Hajdu, Sabina Saini from July 20, 2020 to July 31, 2020.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000760

Details regarding all procedures, requests or recourse currently active, ongoing or pending or any balance owing to you by this Corporation: Solutions NovoAxis Inc.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000763

Details regarding all procedures, requests or recourse currently active, ongoing or pending or any balance owing to you by this Corporation: Solutions NovoAxis Inc.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000795

The rates of male babies and female babies born as a result of artificial insemination procedures done at or in association with the Ottawa Fertility Centre for each year, by year, for the last 6 years.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2020-000767

All records in the possession of Health Canada or any of its associated organizations describing the isolation of the SARS-CoV-2 (Covid-19) virus that was directly taken from a sample of a diseased patient where the patient’s source of the sample was not first combined with any source of other genetic material.

Organization: Health Canada

0 page(s)
September 2020
Date modified: